Micro-Cap Company Discloses Ineffective Controls, Significant Liquidity Issues, and Deteriorating Financials
summarizeSummary
Advanced Oxygen Technologies Inc. reported a significant working capital deficit, declining cash, and a net loss, alongside a critical disclosure of ineffective internal controls and a substantial note payable becoming due in the near term.
check_boxKey Events
-
Ineffective Disclosure Controls
Management concluded that the company's disclosure controls and procedures were not effective as of December 31, 2025, indicating a material weakness in financial reporting.
-
Significant Liquidity Deterioration
The company's working capital shifted from a surplus of $91,958 at June 30, 2025, to a deficit of $(218,931) at December 31, 2025.
-
Substantial Debt Becoming Current
A $127,029 note payable, representing a significant portion of the company's total liabilities, has been reclassified as a current liability and is due by July 1, 2026.
-
Declining Cash Position
Cash and cash equivalents decreased to $33,958 at December 31, 2025, from $57,225 at June 30, 2025.
auto_awesomeAnalysis
This 10-Q filing reveals critical financial and operational challenges for Advanced Oxygen Technologies Inc. The company reported a substantial working capital deficit, a significant decline in cash, and a net loss for the six-month period. Most notably, management concluded that its disclosure controls and procedures were not effective, indicating a material weakness in financial reporting. Furthermore, a $127,029 note payable has become a current liability, due in July 2026, which is a substantial amount compared to the company's cash balance of $33,958. These factors collectively point to severe liquidity concerns and heightened operational risk, making the company's ongoing search for capital or an acquisition critical for its future.
At the time of this filing, AOXY was trading at $0.09 on OTC in the Real Estate & Construction sector, with a market capitalization of approximately $294.7K. The 52-week trading range was $0.02 to $0.82. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.